TREVOR MCFARLAND: Open Payments
NPI 1689104903 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$939 in 71 payments from 17 companies in 2025. Trend: 2023 $898 · 2024 $1,176 · 2025 $939
Food & beverage: $920Education: $19
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 19 | $176 |
| Otsuka America Pharmaceutical, Inc. | 13 | $143 |
| Amgen Inc. | 14 | $135 |
| AstraZeneca Pharmaceuticals LP | 5 | $90 |
| Medtronic, Inc. | 1 | $59 |
| PFIZER INC. | 3 | $59 |
| GlaxoSmithKline, LLC. | 3 | $58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $51 |
| Inspire Medical Systems, Inc. | 2 | $42 |
| Axsome Therapeutics, Inc. | 1 | $19 |
Products named: REXULTI, MOUNJARO, JARDIANCE, EVENITY, AIRSUPRA, SYMPLICITY G3, ELIQUIS, TRELEGY ELLIPTA.
Industry payments across AL — which companies pay providers there.
